Author response for 'Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial'

Autor: null Juan P. Frias, null Guillermo Gonzalez‐Galvez, null Eva Johnsson, null Jill Maaske, null Marcia A. Testa, null Donald C. Simonson, null Nalina Dronamraju, null Ricardo Garcia‐Sanchez, null Anne L. Peters
Rok vydání: 2020
DOI: 10.1111/dom.13997/v2/response1
Databáze: OpenAIRE